Elena Prokupets, Director at C4 Therapeutics, Inc. (CCCC), sold 3,161 shares at $50.04 ($158K) on 2021-09-27, disclosed to the SEC on 2021-09-29.
Open-market sale of $158k CCCC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.04 | 539 | $27K | 17.1% |
| 2 | $50.04 | 1,311 | $66K | 41.5% |
| 3 | $50.04 | 1,311 | $66K | 41.5% |
| Total | $50.04 avg | 3,161 | $158K | 100% |
| Filing → |
| CCCC | SELL | 2021-09-16 | $6.4M | — | Filing → |
| CCCC | SELL | 2021-09-14 | $527K | — | Filing → |
| CCCC | SELL | 2021-08-05 | $1.3M | — | Filing → |